Biomarkers for gastric cancer: Progression in early diagnosis and prognosis

被引：90
作者：
Jin, Ziliang [1 ]
Jiang, Weihua [1 ]
Wang, Liwei [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Oncol, Shanghai Key Lab Pancreat Dis, Shanghai 200080, Peoples R China
来源：
ONCOLOGY LETTERS | 2015年 / 9卷 / 04期
基金：
中国国家自然科学基金;
关键词：
gastric cancer; early diagnosis; prognosis; biological marker; GROWTH-FACTOR RECEPTORS; POOR-PROGNOSIS; MICROSATELLITE INSTABILITY; PROMOTER METHYLATION; EPIGENETIC ALTERATION; POTENTIAL BIOMARKERS; CLINICAL-IMPLICATION; SERUM INTERLEUKIN-6; CELL-PROLIFERATION; GENE POLYMORPHISMS;
D O I：
10.3892/ol.2015.2959
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Gastric cancer is one of leading causes of cancer-related mortality worldwide and is a notable disease due to its heterogeneity. Recently, numerous studies have investigated the molecular basis of gastric cancer, involving the alteration of pathogenesis, and invasion and metastasis. With the development of modern technologies, various novel biomarkers had been identified that appear to possess diagnostic and prognostic value; therefore, the present review describes our current knowledge of biomarkers for the early diagnosis and prognosis of gastric cancer. Classic biomarkers for gastric cancer diagnosis include carcinoembryonic antigen and cancer antigen 19-9, while microRNA and DNA hypomethylation are proposed as novel biomarkers. Excluding classical biomarkers, biomarkers for determining the progression and prognosis of gastric cancer focus on targeting microRNAs, epigenetic alterations and genetic polymorphisms.
引用
收藏
页码：1502 / 1508
页数：7
相关论文
共 116 条
  • [101] Warnecke-Eberz U, 2009, ANTICANCER RES, V29, P4451
  • [102] Wirtz HC, 1998, CLIN CANCER RES, V4, P1749
  • [103] MicroRNA dysregulation in gastric cancer: a new player enters the game
    Wu, W. K. K.
    Lee, C. W.
    Cho, C. H.
    Fan, D.
    Wu, K.
    Yu, J.
    Sung, J. J. Y.
    [J]. ONCOGENE, 2010, 29 (43) : 5761 - 5771
  • [104] MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1
    Xu, Y.
    Zhao, F.
    Wang, Z.
    Song, Y.
    Luo, Y.
    Zhang, X.
    Jiang, L.
    Sun, Z.
    Miao, Z.
    Xu, H.
    [J]. ONCOGENE, 2012, 31 (11) : 1398 - 1407
  • [105] The Effect of XPD/ERCC2 Polymorphisms on Gastric Cancer Risk among Different Ethnicities: A Systematic Review and Meta-Analysis
    Xue, Huiping
    Lu, Yan
    Lin, Bing
    Chen, Jinxian
    Tang, Feng
    Huang, Gang
    [J]. PLOS ONE, 2012, 7 (09):
  • [106] MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer
    Yamanaka, Sumitaka
    Olaru, Alexandru V.
    An, Fangmei
    Luvsanjav, Delgermaa
    Jin, Zhe
    Agarwal, Rachana
    Tomuleasa, Ciprian
    Popescu, Irinel
    Alexandrescu, Sorin
    Dima, Simona
    Chivu-Economescu, Mihaela
    Montgomery, Elizabeth A.
    Torbenson, Michael
    Meltzer, Stephen J.
    Selaru, Florin M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2012, 44 (07) : 589 - 596
  • [107] YASUI W, 1988, CANCER RES, V48, P137
  • [108] DNA Methylation Biomarkers in Serum for Gastric Cancer Screening
    Ye, Ting
    Chen, Yingxuan
    Fang, Jingyuan
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (11) : 1034 - 1038
  • [109] The correlations between the expression of FGFR4 protein and clinicopathological parameters as well as prognosis of gastric cancer patients
    Ye, Yan-Wei
    Zhang, Xiefu
    Zhou, Ye
    Wu, Jianghong
    Zhao, Chunlin
    Yuan, Lin
    Wang, Guojun
    Du, Chunyan
    Wang, Chunmeng
    Shi, Yingqiang
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (07) : 872 - 879
  • [110] CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer
    Yu, Qi-Ming
    Wang, Xin-Bao
    Luo, Jun
    Wang, Shi
    Fang, Xian-Hua
    Yu, Jiang-Liu
    Ling, Zhi-Qiang
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (06) : 765 - 771
3456789101112